Mainly because it can connect with other medicines, Zokinvy (lonafarnib) shouldn't be taken together with a strong or moderate CYP3A inhibitor or inducer, as well as midazolam and selected cholesterol-decreasing medicines.1Medical trials have demonstrated that Zokinvy can appreciably boost survival and quality of life for youngsters with progeria,